Literature DB >> 22299597

Pentosan polysulfate increases affinity between ADAMTS-5 and TIMP-3 through formation of an electrostatically driven trimolecular complex.

Linda Troeberg1, Barbara Mulloy, Peter Ghosh, Meng-Huee Lee, Gillian Murphy, Hideaki Nagase.   

Abstract

The semi-synthetic sulfated polysaccharide PPS (pentosan polysulfate) increases affinity between the aggrecan-degrading ADAMTSs (adamalysins with thrombospondin motifs) and their endogenous inhibitor, TIMP (tissue inhibitor of metalloproteinases)-3. In the present study we demonstrate that PPS mediates the formation of a high-affinity trimolecular complex with ADAMTS-5 and TIMP-3. A TIMP-3 mutant that lacks extracellular-matrix-binding ability was insensitive to this affinity increase, and truncated forms of ADAMTS-5 that lack the Sp (spacer) domain had reduced PPS-binding ability and sensitivity to the affinity increase. PPS molecules composed of 11 or more saccharide units were 100-fold more effective than those of eight saccharide units, indicating the involvement of extended or multiple protein-interaction sites. The formation of a high-affinity trimolecular complex was completely abolished in the presence of 0.4 M NaCl. These results suggest that PPS enhances the affinity between ADAMTS-5 and TIMP-3 by forming electrostatically driven trimolecular complexes under physiological conditions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22299597      PMCID: PMC3369482          DOI: 10.1042/BJ20112159

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  39 in total

1.  Conformational flexibility and allosteric regulation of cathepsin K.

Authors:  Marko Novinec; Lidija Kovacic; Brigita Lenarcic; Antonio Baici
Journal:  Biochem J       Date:  2010-07-15       Impact factor: 3.857

2.  TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5).

Authors:  M Kashiwagi; M Tortorella; H Nagase; K Brew
Journal:  J Biol Chem       Date:  2001-01-23       Impact factor: 5.157

3.  Molecular weight measurements of low molecular weight heparins by gel permeation chromatography.

Authors:  B Mulloy; C Gee; S F Wheeler; R Wait; E Gray; T W Barrowcliffe
Journal:  Thromb Haemost       Date:  1997-04       Impact factor: 5.249

4.  Crystal structures of catrocollastatin/VAP2B reveal a dynamic, modular architecture of ADAM/adamalysin/reprolysin family proteins.

Authors:  Tomoko Igarashi; Satohiko Araki; Hidezo Mori; Soichi Takeda
Journal:  FEBS Lett       Date:  2007-04-30       Impact factor: 4.124

5.  ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro.

Authors:  Heather Stanton; Fraser M Rogerson; Charlotte J East; Suzanne B Golub; Kate E Lawlor; Clare T Meeker; Christopher B Little; Karena Last; Pamela J Farmer; Ian K Campbell; Anne M Fourie; Amanda J Fosang
Journal:  Nature       Date:  2005-03-31       Impact factor: 49.962

6.  Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement.

Authors:  S T Olson; I Björk; R Sheffer; P A Craig; J D Shore; J Choay
Journal:  J Biol Chem       Date:  1992-06-25       Impact factor: 5.157

7.  Antithrombin-S195A factor Xa-heparin structure reveals the allosteric mechanism of antithrombin activation.

Authors:  Daniel J D Johnson; Wei Li; Ty E Adams; James A Huntington
Journal:  EMBO J       Date:  2006-04-13       Impact factor: 11.598

8.  A catalytic role of heparin within the extracellular matrix.

Authors:  Maria Mitsi; Kimberly Forsten-Williams; Manoj Gopalakrishnan; Matthew A Nugent
Journal:  J Biol Chem       Date:  2008-10-09       Impact factor: 5.157

9.  Increased backbone mobility in beta-barrel enhances entropy gain driving binding of N-TIMP-1 to MMP-3.

Authors:  S Arumugam; Guanghua Gao; Brian L Patton; Valentyna Semenchenko; Keith Brew; Steven R Van Doren
Journal:  J Mol Biol       Date:  2003-03-28       Impact factor: 5.469

10.  Structure of the antithrombin-thrombin-heparin ternary complex reveals the antithrombotic mechanism of heparin.

Authors:  Wei Li; Daniel J D Johnson; Charles T Esmon; James A Huntington
Journal:  Nat Struct Mol Biol       Date:  2004-08-15       Impact factor: 15.369

View more
  13 in total

Review 1.  Cell-matrix interactions: focus on proteoglycan-proteinase interplay and pharmacological targeting in cancer.

Authors:  Achilleas D Theocharis; Chrisostomi Gialeli; Panagiotis Bouris; Efstathia Giannopoulou; Spyros S Skandalis; Alexios J Aletras; Renato V Iozzo; Nikos K Karamanos
Journal:  FEBS J       Date:  2014-11-06       Impact factor: 5.542

2.  Alternative splicing of the metalloprotease ADAMTS17 spacer regulates secretion and modulates autoproteolytic activity.

Authors:  Zerina Balic; Saurav Misra; Belinda Willard; Dieter P Reinhardt; Suneel S Apte; Dirk Hubmacher
Journal:  FASEB J       Date:  2021-02       Impact factor: 5.834

3.  Injectable and bioresponsive hydrogels for on-demand matrix metalloproteinase inhibition.

Authors:  Brendan P Purcell; David Lobb; Manoj B Charati; Shauna M Dorsey; Ryan J Wade; Kia N Zellars; Heather Doviak; Sara Pettaway; Christina B Logdon; James A Shuman; Parker D Freels; Joseph H Gorman; Robert C Gorman; Francis G Spinale; Jason A Burdick
Journal:  Nat Mater       Date:  2014-03-30       Impact factor: 43.841

4.  Systems Based Study of the Therapeutic Potential of Small Charged Molecules for the Inhibition of IL-1 Mediated Cartilage Degradation.

Authors:  Saptarshi Kar; David W Smith; Bruce S Gardiner; Alan J Grodzinsky
Journal:  PLoS One       Date:  2016-12-15       Impact factor: 3.240

5.  Suramin Inhibits Osteoarthritic Cartilage Degradation by Increasing Extracellular Levels of Chondroprotective Tissue Inhibitor of Metalloproteinases 3.

Authors:  Anastasios Chanalaris; Christine Doherty; Brian D Marsden; Gabriel Bambridge; Stephen P Wren; Hideaki Nagase; Linda Troeberg
Journal:  Mol Pharmacol       Date:  2017-08-10       Impact factor: 4.436

6.  Low density lipoprotein receptor-related protein 1 (LRP1)-mediated endocytic clearance of a disintegrin and metalloproteinase with thrombospondin motifs-4 (ADAMTS-4): functional differences of non-catalytic domains of ADAMTS-4 and ADAMTS-5 in LRP1 binding.

Authors:  Kazuhiro Yamamoto; Kathryn Owen; Andrew E Parker; Simone D Scilabra; Jayesh Dudhia; Dudley K Strickland; Linda Troeberg; Hideaki Nagase
Journal:  J Biol Chem       Date:  2014-01-28       Impact factor: 5.157

7.  Pentosan polysulfate: a novel therapy for the mucopolysaccharidoses.

Authors:  Edward H Schuchman; Yi Ge; Alon Lai; Yury Borisov; Meghan Faillace; Efrat Eliyahu; Xingxuan He; James Iatridis; Helen Vlassara; Gary Striker; Calogera M Simonaro
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

8.  Antibody-based exosite inhibitors of ADAMTS-5 (aggrecanase-2).

Authors:  Salvatore Santamaria; Kazuhiro Yamamoto; Kenneth Botkjaer; Christopher Tape; Michael R Dyson; John McCafferty; Gillian Murphy; Hideaki Nagase
Journal:  Biochem J       Date:  2015-08-24       Impact factor: 3.857

9.  Sulfated glycosaminoglycans control the extracellular trafficking and the activity of the metalloprotease inhibitor TIMP-3.

Authors:  Linda Troeberg; Christopher Lazenbatt; Md Ferdous Anower-E-Khuda; Craig Freeman; Oleg Federov; Hiroko Habuchi; Osami Habuchi; Koji Kimata; Hideaki Nagase
Journal:  Chem Biol       Date:  2014-08-28

10.  Improved clinical outcome measures of knee pain and function with concurrent resolution of subchondral Bone Marrow Edema Lesion and joint effusion in an osteoarthritic patient following Pentosan Polysulphate Sodium treatment: a case report.

Authors:  Matthew J Sampson; Margie Kabbani; Ravi Krishnan; Michael Nganga; Annika Theodoulou; Jeganath Krishnan
Journal:  BMC Musculoskelet Disord       Date:  2017-09-12       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.